Skip to main content
OpenTrials

Clinical trial condition

Platinum-Sensitive Fallopian Tube Carcinoma

Explore clinical trials studying Platinum-Sensitive Fallopian Tube Carcinoma. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Platinum-Sensitive Fallopian Tube Carcinoma trial results

Completed

Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors

NCT05002868

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +18 more
Locations
  • Multiscan s.r.o. Hořovice, Czechia
  • SP ZOZ University Hospital in Krakow Oncology Clinic, 50 Kopernika Street Krakow, Poland
  • Klinika Onkologii ICZMP Lodz, Poland
  • Pratia Poznań Medical Center Poznan, Poland
View Trial Details
Active, Not Recruiting

Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer

NCT04034927

Conditions
Adnexal Diseases, Fallopian Tube Diseases, Fallopian Tube Endometrioid Tumor, +23 more
Locations
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Hartford Hospital Hartford, Connecticut, United States
  • Augusta University Medical Center Augusta, Georgia, United States
View all 20 locations
View Trial Details

Related conditions